BMC Cancer

1. SU Y, Liang Y, Zhong D, Yan H, et al
   Construction and validation of a novel liver function-tumor burden-inflammation-nutrition (LTIN) score for HCC patients underwent hepatectomy.
   BMC Cancer. 2025;25:504.
   

   >> Share

   
   
2. SONG S, Zhang G, Yao Z, Chen R, et al
   Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma.
   BMC Cancer. 2025;25:497.
   

   >> Share

   
   
3. WANG Y, Yang Z, Li Z, Huang L, et al
   Proteomics-driven discovery of LCAT as a novel biomarker for liver metastasis in colorectal cancer.
   BMC Cancer. 2025;25:480.
   

   >> Share

   
   
4. TANG H, Chai C, Miao X, Su Y, et al
   Establishment and characterization of CHC-X1: the third human combined hepatocellular-cholangiocarcinoma cell line.
   BMC Cancer. 2025;25:472.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. ZHANG L, Bai L
   Diagnostic performance of contrast-enhanced CT combined with contrast-enhanced MRI for colorectal liver metastases: a case-control study.
   BMC Gastroenterol. 2025;25:188.
   

   >> Share

   
   
6. YU C, Chen L, Hu W, Lei X, et al
   The role of the advanced lung cancer inflammation index (ALI) in the risk of liver fibrosis and mortality among US adult MAFLD patients: a cross-sectional study of NHANES 1999-2018.
   BMC Gastroenterol. 2025;25:190.
   

   >> Share

   
   
7. ZHANG W, Kang N, Wang Y, Zhang F, et al
   Endoscopic treatment for gastroesophageal varices in patients with cirrhosis: a survey comparing between developed and developing countries.
   BMC Gastroenterol. 2025;25:176.
   

   >> Share

   
   

   
   Dig Dis Sci

8. PIETRI O, Chicaud M, Andreani T, Chretien Y, et al
   Unexplained Chronically Elevated Aminotransferases: Liver Biopsy Gives Major Information with Therapeutic Implication in One Patient Out of Seven.
   Dig Dis Sci. 2025;70:1178-1189.
   

   >> Share

   
   
9. ZHANG J, Yang Z, Liu X, Yang X, et al
   New Insights into the Pathogenesis of Alcoholic Liver Disease Based on Global Research.
   Dig Dis Sci. 2025;70:903-918.
   

   >> Share

   
   
10. CHIEN SC, Chiu HC, Chiu YC, Wang RH, et al
    Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD).
    Dig Dis Sci. 2025;70:1190-1200.
    

    >> Share

    
    
11. JAGDISH B, Murone J, Venkat D
    Implementation of Alcohol Use Disorder Training Curriculum Improves Perceived Confidence in Treating Alcohol-Related Liver Disorder Amongst Gastroenterology Fellows.
    Dig Dis Sci. 2025;70:1000-1007.
    

    >> Share

    
    

    
    Eur Radiol

12. CANNELLA R, Agnello F, Porrello G, Spinello AU, et al
    Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease.
    Eur Radiol. 2025;35:2339-2350.
    

    >> Share

    
    
13. REITHMEIER B, Laun FB, Fuhres T, Uder M, et al
    Relevance of lesion size in navigator-triggered and free-breathing diffusion-weighted liver MRI.
    Eur Radiol. 2025;35:2106-2115.
    

    >> Share

    
    
14. ZHANG Y, Huang C, Meng F, Hu X, et al
    Non-invasive assessment of esophageal and fundic varices in patients with primary biliary cholangitis.
    Eur Radiol. 2025;35:2330-2338.
    

    >> Share

    
    

    
    Hepatology

15. GE J, Fontil V, Ackerman S, Pletcher MJ, et al
    Clinical decision support and electronic interventions to improve care quality in chronic liver diseases and cirrhosis.
    Hepatology. 2023 Aug 23. doi: 10.1097/HEP.0000000000000583.
    

    >> Share

    
    
16. ZANUSO V, Rimassa L, Braconi C
    The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy.
    Hepatology. 2025;81:1365-1386.
    

    >> Share

    
    
17. STALLER DW, Panigrahi SS, Jayasinghe YP, Dong Y, et al
    A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases.
    Hepatology. 2025;81:1288-1303.
    

    >> Share

    
    
18. HLADY RA, Zhao X, El Khoury LY, Wagner RT, et al
    Epigenetic heterogeneity hotspots in human liver disease progression.
    Hepatology. 2025;81:1197-1210.
    

    >> Share

    
    
19. LEFERE S, Mosca A, Hudert C, Dupont E, et al
    Development and validation of pFIB scores for exclusion of significant liver fibrosis in pediatric MASLD.
    Hepatology. 2025;81:1276-1287.
    

    >> Share

    
    
20. OJHA U, Kim S, Rhee CY, You J, et al
    Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis.
    Hepatology. 2025;81:1228-1243.
    

    >> Share

    
    
21. WANG M, Chiou SH, Ganger D, Ruck J, et al
    Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study.
    Hepatology. 2024 Jul 24. doi: 10.1097/HEP.0000000000001030.
    

    >> Share

    
    
22. NOBEL YR, Boike JR, Mazumder NR, Thornburg B, et al
    Predictors of long-term clinical outcomes after TIPS: An ALTA group study.
    Hepatology. 2025;81:1244-1255.
    

    >> Share

    
    

    
    Int J Cancer

23. PATEL DP, Loffredo CA, Pupacdi B, Rabibhadana S, et al
    Associations of chronic liver disease and liver cancer with glyphosate and its metabolites in Thailand.
    Int J Cancer. 2025;156:1885-1897.
    

    >> Share

    
    

    
    J Comput Assist Tomogr

24. SETIAWAN H, Ria F, Abadi E, Marin D, et al
    Development and Clinical Evaluation of a Contrast Optimizer for Contrast-Enhanced CT Imaging of the Liver.
    J Comput Assist Tomogr. 2025;49:239-246.
    

    >> Share

    
    

    
    J Gastroenterol

25. HANAMATSU H, Suda G, Ohara M, Ogawa K, et al
    Elevated A2F bisect N-glycans of serum IgA reflect progression of liver fibrosis in patients with MASLD.
    J Gastroenterol. 2025;60:456-468.
    

    >> Share

    
    

    
    J Hepatol

26. RAN S, Zhang J, Tian F, Qian ZM, et al
    Association of metabolic signatures of air pollution with MASLD: Observational and Mendelian randomization study.
    J Hepatol. 2025;82:560-570.
    

    >> Share

    
    
27. YANG X, Deng B, Zhao W, Guo Y, et al
    FABP5(+) lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity.
    J Hepatol. 2025;82:676-689.
    

    >> Share

    
    
28. BURKE L, Bernal W, Pirani T, Agarwal B, et al
    Plasma exchange does not improve overall survival in patients with acute liver failure in a real-world cohort.
    J Hepatol. 2025;82:615-621.
    

    >> Share

    
    
29. VILAR-GOMEZ E, Gawrieh S, Vuppalanchi R, Kettler C, et al
    PNPLA3 rs738409, environmental factors and liver-related mortality in the US population.
    J Hepatol. 2025;82:571-581.
    

    >> Share

    
    
30. MEIJNIKMAN AS, Fondevila MF, Arrese M, Kisseleva T, et al
    Towards more consistent models and consensual terminology in preclinical research for steatotic liver disease.
    J Hepatol. 2025;82:760-766.
    

    >> Share

    
    
31. ARAB JP, Diaz LA, Rehm J, Im G, et al
    Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease.
    J Hepatol. 2025;82:744-756.
    

    >> Share

    
    

    
    PLoS Genet

32. CHEN L, Yang H, Wang J, Zhang H, et al
    MEOX1-mediated transcriptional regulation of circABHD3 exacerbates hepatic fibrosis through promoting m6A/YTHDF2-dependent YPEL3 mRNA decay to activate beta-catenin signaling.
    PLoS Genet. 2025;21:e1011622.
    

    >> Share

    
    

    
    PLoS One

33. ADEYEMI O, Osuntoki A, Magbagbeola O, Abdel Hamid MM, et al
    Evidence for infectious merozoites of Plasmodium falciparum from natural isolates of cultured hepatoma cells infected with sporozoites.
    PLoS One. 2025;20:e0319901.
    

    >> Share

    
    
34. CHEN K, Yang M, Li G, Wang W, et al
    Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0317730.
    

    >> Share

    
    
35. LIN L, Xie Y, Lin Z, Lin C, et al
    Machine learning for predicting metabolic-associated fatty liver disease including NHHR: a cross-sectional NHANES study.
    PLoS One. 2025;20:e0319851.
    

    >> Share

    
    

    
    Radiology

36. DELL T, Mesropyan N, Layer Y, Tischler V, et al
    Photon-counting CT-derived Quantification of Hepatic Fat Fraction: A Clinical Validation Study.
    Radiology. 2025;314:e241677.
    

    >> Share

    
    

    
    Transplant Proc

37. WANG H, Qu W, Liu Y, Zhang L, et al
    Recurrence of Myopathy After Liver Transplantation for Patients With End-Stage GSD Type IIIa.
    Transplant Proc. 2025 Mar 3:S0041-1345(25)00093.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share